These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 5288229

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Fertility control with Ovral. A clinical review.
    Laurie RE, Lewis ET.
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:95-107. PubMed ID: 4256548
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo.
    Cullberg J.
    Acta Psychiatr Scand Suppl; 1972 Dec; 236():1-86. PubMed ID: 4565340
    [No Abstract] [Full Text] [Related]

  • 6. Low-oestrogen combined oral contraceptive.
    Foss GL, Fotherby K.
    Acta Eur Fertil; 1973 Jun; 4(2):57-8. PubMed ID: 4784140
    [No Abstract] [Full Text] [Related]

  • 7. Fertility control with norgestrel and ethynil estradiol. Report on continuing studies.
    Rice-Wray E, Cervantes A, Garcilazo J, Valenzuela P.
    J Reprod Med; 1972 Aug; 9(2):45-9. PubMed ID: 5050402
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A double-blind comparison of two oral contraceptives containing 50 mu g. and 30 mu g. ethinyl estradiol.
    Dionne P, Vickerson F.
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):281-8. PubMed ID: 4208342
    [Abstract] [Full Text] [Related]

  • 11. Eight years of fertility control with norgestrel-ethinyl estradiol (Ovral): an updated clinical review.
    Korba VD, Heil CG.
    Fertil Steril; 1975 Oct; 26(10):973-81. PubMed ID: 1183625
    [Abstract] [Full Text] [Related]

  • 12. [Use of Ovidon, Rigevidon and Postinor for contraception].
    Kulakov VI, Barinov AM, Prilepskaia VN.
    Akush Ginekol (Mosk); 1983 Nov; (11):22-4. PubMed ID: 6666791
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Clinical trials of an association of norgestrel and ethinyl estradiol commercialized under the name of Stediril].
    Gaudefroy M, Corette L, Coliche D.
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971 Nov; 23(4):434. PubMed ID: 5153231
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical trial of a low dose combined oral contraceptive ('Ovranette').
    Foss GL, Fotherby K.
    Curr Med Res Opin; 1975 Nov; 3(2):72-6. PubMed ID: 1095309
    [Abstract] [Full Text] [Related]

  • 18. Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg.
    Christie T.
    J Reprod Med; 1983 Jan; 28(1 Suppl):63-5. PubMed ID: 6403701
    [No Abstract] [Full Text] [Related]

  • 19. Plasma prolactin concentrations in women treated with low dose combination type oral contraceptives and in women using a d-norgestrel-releasing intrauterine device.
    Nilsson CG, Lähteenmäki P.
    Ann Clin Res; 1978 Aug; 10(4):242-5. PubMed ID: 707973
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.